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I. Introduction
Cancer is a general term for a large group of diseases characterized by the growth of abnormal 
cells outside the boundary that can attack neighboring parts of the body and / or spread to other 
organs. Other general terms used are malignant tumors and neoplasms. Cancer can affect almost all 
parts of the body and has many anatomic and molecular subtypes. In 2018, according to the World 
Health Organization, cancer is the second leading cause of death globally and accounts for 9.6 
million deaths. Lung, prostate, colorectal, stomach and liver cancers are the most common types of 
cancer in men, while breast, colorectal, lung, cervical and stomach cancers are the most common in 
women [1]. Based on available data, 30% and 50% of cancer deaths can be prevented by avoiding 
the main risk factors, including avoiding tobacco products, reducing alcohol consumption, 
maintaining a healthy weight, exercising regularly and overcoming risk factors associated with 
infection. In addition, early detection of cancer can also increase the success of treatment in patients 
with cancer [2], [3]. 
In the latest research, cancer can be detected through DNA Microarrays. Someone who suffers 
from cancer will experience changes in the value of expression of certain genes [4]. Normal cells 
can evolve into dangerous cancer cells through a series of cell mutation that can control the cell 
cycle, apoptosis and genome integrity, and others [4], [5]. Using DNA microarrays can support 
effectiveness in identifying gene function and diagnosing cancer [6]–[9]. 
However, problems arise when detecting cancer using Microarray data. Very high dimensions in 
microarray data cause the data cannot be processed immediately using classification method. 
Vanitha conducted research in the classification of Colon tumors and Lymphoma datasets using 
Mutual Information (MI) and Support Vector Machines [10]. Nurfalah [11] uses Principal 
Component Analysis (PCA) and Conjugate Gradient — Backpropagation methods to detect Ovarian 
Cancer, Colon Tumor and Leukemia. Seeja.K.R. [12], constructing the F-Score scheme and SVM as 
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Microarray's feature selection and classifier, Kumar et al. uses the method of T-test feature selection 
and Functional Link Neural Network (FLNN) as a classifier [13], Bharathi used the Analysis of 
Variance (ANOVA) and Support Vector Machine (SVM) as feature selection and classifiers [14], 
and Diaz uses the Random Forest method [15]. Adiwijaya [16] also conducted research on the 
classification of cancer using PCA as a dimension reduction method as well as SVM and 
Backpropagation - Levenberg Marquardt (BPLM) as a classification method. In this study an 
average accuracy of 96.07 using BPLM and 94.98 using SVM can be achieved. Untari [17] uses 
Deep Belief Network and Mutual Information for microarray data classification and achieves an 
accuracy of 90.84%. 
From some dimension reduction methods above, there are difficulties in determining how many 
attributes to choose, so the determination of number of attributes must be done by trial and error. 
Untari [18] uses the Genetic Algorithm and Momentum Backpropagation to classify Colon tumors 
and leukemia with 98.33% performance for Colon Tumor and 100% for Leukemia. By using the 
Genetic Algorithm, the selection of important attributes can be done by utilizing an evolutionary 
scheme so that the selected attributes are truly important attributes. However, in the Momentum 
Backpropagation method the value of learning rate is still static and need more time to converge, so 
certain mechanisms are needed to resolve the problem. Therefore, in this research optimization of 
the Momentum Backpropagation method is done by adding an adaptive learning rate scheme. With 
the adaptive learning rate scheme, it is expected that the system learning time will be faster. 
II. Proposed Method 
The novelty proposed in this study is the optimization of the Momentum Backpropagation 
algorithm in detecting cancer based on DNA microarray data. The optimization is done by 
dynamically adjusting the value of learning rate at each epoch in the training process. The 
optimization process is done by adding an adaptive learning rate scheme to the training process. This 
optimization process is needed to increase the level of convergence of the Momentum 
Backpropagation algorithm so that the training process will be faster and require less iteration. In 
this research, Genetic Algorithms are also used as a feature selection / reduction method of DNA 
microarray data dimensions that have very high dimensions. Genetic Algorithm is used because the 
method can choose the optimal features automatically using the evolution process, so that the 
number of features selected is not done by trial and error. With the proposed scheme, it is expected 
that the training process can be faster with a high level of detection accuracy. 
III. Methodology 
At this stage the researchers designed a feature selection method using genetic algorithms to 
select optimal features from Microarray data which will be used in the classification process, as well 
as designing the learning and testing stages of the Momentum Backpropagation method by adding 
an adaptive learning rate scheme. The addition of adaptive learning rate is done by multiplying the 
value of the learning rate with the increment learning rate parameter if the error value is large, and 
reducing the value of the learning rate by multiplying it with the decrement learning rate parameter 
if the error value is small. In addition, also determined parameters that affect the performance of 
genetic algorithms and the Momentum Backpropagation method used, so that the cancer detection 
system built can have a high performance. The following pseudo code (Table 1) describes the stages 
of a cancer detection system based on DNA microarray data. 
The system built begins with the processing of a cancer dataset in the form of one of the gene 
expression data, microarrays. There are four datasets used, namely Colon Tumors, Leukemia, Lung 
Cancer, and Ovarian Cancer. The data was obtained through the Kent Ridge Database Repository 
[19]. The data specifications to be used can be seen in Table 2. The data undergoes a normalization 
process because the range of data for each attribute can vary [20]. Furthermore, in the method used 
there is the training and testing process. The training process is used to train the model in order to 
get the most optimal model, and the model will be tested for performance in the testing process. 
Therefore, in one dataset will be divided into two parts, namely training data and testing data. 
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Table 1. Pseudo Code of Proposed Scheme of Cancer Detection System. 
Input: DNA microarray dataset. 
Preprocessing: normalization process. 
Splitting dataset (training and testing data) 
Training process: 
Input: training data. 
Initialize population using binary representation. 
Repeat: 
Decode chromosome (feature selection). 
Evaluate each chromosome (Momentum Backpropagation with adaptive learning rate training). 
Crossover process using one-point crossover. 
Mutation process using binary mutation. 
Survivor selection using general replacement and elitism. 
Until: max generation reached. 
Output training process: optimal features index, optimal params/weights of Neural Network. 
Testing process: 
Input: testing data, optimal features index, optimal params/weights of Neural Network. 
Feature selection based on optimal features index. 
Cancer detection for each data: Neural Network testing using optimal params/weights of Neural Network. 
Calculate testing accuracy. 
Output testing process: detection results and testing accuracy. 
Table 2. DNA Microarray Dataset Specification. 
Dataset Number of Sample Number of Feature 
Colon 62 (22 Positive, 40 Negative) 2001 
Leukemia 72 (24 ALL, 28 AML, 20 MLL) 12582 
Ovarian 253 (91 Normal, 162 Cancer) 15155 
Lung Cancer 181 (31 Mesothelioma, 150 ADCA) 12533 
 
In the training process, Genetic Algorithms are used as a feature selection method and Neural 
Network with the Momentum Backpropagation training algorithm as a microarray data classification 
method. The genetic algorithm will select the important features contained in the microarray data 
through an evolutionary process. The Genetic Algorithm training process begins with population 
initialization, in which at this stage a number of individuals are generated (according to a 
predetermined population size) randomly according to the chromosome representation that was 
previously designed. Because the Genetic Algorithm in this study is used as a feature selection 
method, the chromosome that is designed has a dimension of 1xN, where N is the number of 
attributes of the data used [18]. Then the chromosomes are represented using binary numbers, where 
"1" means the features in the corresponding column are selected, and 0 vice versa. Furthermore, the 
chromosome decoding process is done by selecting features in the data used according to the 
chromosome index value of 1. 
Chromosome evaluation is done by calculating the fitness value of each chromosome. The fitness 
function used to calculate the fitness value is the accuracy of training data obtained from the 
Momentum Backpropagation training process [21], [22]. The Momentum Backpropagation training 
process aims to find the weights of the Neural Network architecture, where the architecture of Multi-
Layer Neural Network is determined at the beginning how many hidden layer and hidden neurons 
are used [23]. In this process there are three training algorithms used, namely Momentum 
Backpropagation, Backpropagation with adaptive learning rate schemes, and Momentum 
Backpropagation with adaptive learning rate schemes [24], [25], [26]. 
Then, the next process is the process of evolution of Genetic Algorithms, which consists of 
parents selection, crossover, mutation, and survivor selection. Parents selection, to look for parental 
pairs that will be used in the crossover process (recombination). The parent selection scheme used is 
the Roulette Wheel, which is the selection of parents carried out randomly according to the 
proportion of fitness value [27]. Crossover, the process of exchanging parent genes to form the 
chromosomes of children. In a standard genetic algorithm, two parent chromosomes will produce 
two child chromosomes. The recombination process is carried out if the random number raised is 
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less than the specified recombination probability. The crossover operator used in this study is one 
point crossover [28]. 
Mutation, the process of reversing genes in chromosomes where the number 0 will become 1, 
and vice versa. The mutation process is carried out if the random number generated is less than the 
probability of the mutation that has been determined. In this study flip mutations are used [29]. 
Survivor selection, to choose chromosomes that will survive / enter the next generation. In this study 
the Generational Replacement survivor selection scheme [30] is used, in which the child 
chromosomes will replace the chromosomes in the current generation. Therefore, the elitism process 
is needed to maintain chromosomes with the highest fitness value so that they are not replaced by 
chromosomes of lower quality. 
The evolution process will be repeated as many generations as determined, and at the end of the 
training process the system will store the best chromosomes and their optimal weights for use in the 
testing process. The testing process is an activity of testing the system that has been implemented 
along with parameters that have been obtained during the learning phase. This process begins with 
the feature selection based on the best chromosomes obtained in the training process, so the testing 
data used is data that has been reduced by the number of attributes. Then the classification process 
uses the Neural Network architecture and the optimal weights from the training process and perform 
forward propagation to determine the Neural Network output. As for what will be observed and 
analyzed from the system that has been built include: 
a. Effect of genetic algorithm parameters used as a feature selection method on system 
performance. 
b. Effect of momentum parameters and adaptive learning rate on the learning process. 
IV. Results and Discussion 
The research conducted aims to build a cancer detection system based on Microarray data using 
Genetic Algorithms as a feature selection method and Momentum Backpropagation - Neural 
Network by adding an adaptive learning rate scheme for Microarray data classification that has been 
reduced in dimensions. In addition, in this study also compares and analyzes the performance of the 
system uses Momentum Backpropagation, Backpropagation with the adaptive learning rate scheme, 
and Momentum Backpropagation with the adaptive learning rate scheme. The combination of 
parameters used in this study to find the best model are population size, cross-move probability, 
mutation probability, number of hidden neurons, learning rate, increment learning rate, decrement 
learning rate, and momentum. Detail range of each parameter can be seen in Table 3. 
Table 3. Combination of Genetic Algorithm Parameters and Backpropagation Momentum - Neural Network 
with Adaptive Learning Rate. 
Parameter Value 
Population size [25, 50, 100] 
Crossover probability [0.5 0.7 0.9] 
Mutation probability [0.05 0.1 0.2] 
Number of hidden neurons [5, 10] 
Leaning Rate [0.05; 0.1; 0.15; 0.2] 
Increment Learning Rate [1.05; 1.15; 1.25] 
Decrement Learning Rate [0.65; 0.75; 0.85] 
Momentum [0.8; 0.85; 0.9; 0.95] 
 
The test results with the specified parameters are proven to be able to detect cancer based on 
Microarray data classification, and the addition of an adaptive learning rate scheme to the 
Momentum Backpropagation algorithm can improve the accuracy of the cancer detection system. 
Table 4 shows the best combination parameter results of Genetic Algorithm and Momentum 
Backpropagation Algorithm for each dataset. Hyper parameters observed were population size, 
cross-move probability, mutation probability, number of hidden neurons, and Momentum 
Backpropagation algorithm parameters (learning rate and momentum). The best testing accuracy 
that can be achieved using Genetic Algorithm and Momentum Backpropagation Algorithm (Table 
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4) is 88.84% for Colon Tumor data, 98.66% for Leukemia data, 99.44% for Lung Cancer data, and 
99.6% for Ovarian Cancer data. 
Table 4. The Best Combination Parameters of Genetic Algorithms and Momentum Backpropagation 
Algorithm in Cancer Detection System. 
Hyper Parameter Colon Tumor Leukimia Lung Cancer Ovarian Cancer 
Population size 50 25 25 100 
Crossover probability 0.5 0.9 0.5 0.7 
Mutation probability 0.05 0.05 0.05 0.1 
Number of hidden neurons 15 5 5 5 
Leaning rate 0.05 0.1 0.05 0.1 
Momentum 0.8 0.8 0.8 0.8 
Training accuracy 92.35% 100% 99.86% 99.50% 
Testing accuracy 88.84% 98.66% 99.44% 99.60% 
Number of epochs 228 84 617 628 
MSE 0.0729 0.0024 0.0008 0.0048 
Table 5. The Best Combination Parameters of Genetic Algorithms and Backpropagation Algorithm with 
Adaptive Learning Rate in Cancer Detection System. 
Hyper Parameter Colon Tumor Leukimia Lung Cancer Ovarian Cancer 
Population size 50 25 25 25 
Crossover probability 0.5 0.7 0.9 0.5 
Mutation probability 0.05 0.05 0.2 0.1 
Number of hidden neurons 10 5 5 5 
Leaning rate 0.15 0.15 0.15 0.1 
Increment learning rate 1.05 1.25 1.15 1.05 
Decrement learning rate 0.75 0.65 0.85 0.65 
Training accuracy 96.37% 100% 100% 100% 
Testing accuracy 90.51% 98.66% 100% 100% 
Number of epochs 189 86 159 189 
MSE 0.02970 0.0013 0.00099 0.0012 
Table 6. The Best Combination Parameters of Genetic Algorithms and Momentum Backpropagation 
Algorithm with Adaptive Learning Rate in Cancer Detection System. 
Hyper Parameter Colon Tumor Leukimia Lung Cancer Ovarian Cancer 
Population size 50 25 25 25 
Crossover probability 0.9 0.7 0.7 0.9 
Mutation probability 0.2 0.1 0.05 0.1 
Number of hidden neurons 10 5 5 5 
Leaning rate 0.05 0.15 0.05 0.2 
Increment learning rate 1.15 1.25 1.15 1.05 
Decrement learning rate 0.65 0.75 0.65 0.65 
Momentum 0.9 0.8 0.8 0.85 
Training accuracy 93.96% 100% 100% 100% 
Testing accuracy 90.5% 100% 100% 100% 
Number of epochs 48 39 61 154 
MSE 0.0506 0.0100 0.00021 0.00035 
 
The next algorithm tested is the Backpropagation algorithm by adding an adaptive learning rate, 
and the results are presented in Table 5. Hyper parameters observed were population size, crossover 
probability, mutation probability, number of hidden neurons, and Backpropagation algorithm with 
an adaptive learning rate parameter (learning rate, increment learning rate, and decrement learning 
rate). The best testing accuracy that can be achieved using Genetic Algorithms and Backpropagation 
Algorithm with Adaptive Learning Rate (Table 5) is 90.51% for Colon Tumor data, 98.66% for 
Leukemia data, 100% for Lung Cancer data, and 100% for Ovarian Cancer data. Then to improve 
the performance and processing time of the Momentum Backpropagation algorithm, an adaptive 
learning rate scheme is added. This is done by combining the Backpropagation Momentum and 
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Backpropagation algorithms with the adaptive learning rate, where the results are presented in Table 
6. Hyper parameters observed are population size, crossover probability, mutation probability, 
number of hidden neurons, and Momentum Backpropagation algorithm with adaptive learning rate 
schemes parameters (learning rate, momentum, increment learning rate, and decrement learning 
rate). The best testing accuracy that can be achieved using Genetic Algorithms and Momentum 
Backpropagation Algorithm with Adaptive Learning Rate (Table 6) is 90.5% for Colon Tumor data, 
100% for Leukemia data, 100% for Lung Cancer data, and 100% for Ovarian Cancer data. 
Based on the best combination of parameters in Table 4, Table 5, and Table 6, each dataset and 
cancer detection scheme have the best combination of different parameters. This shows that the use 
of hyper parameter values is very dependent on the algorithm and dataset used. Population size 
parameter indicates how much exploration the search for solutions performed, crossover and 
mutation probability shows how much the level of crossover and mutation operations are carried 
out, number of hidden neurons shows how complex the classification functions required for data 
classification, learning rate and momentum indicate how large the step width needed to reach the 
convergent point, and the learning rate increment and decrement are used to increase or decrease the 
value of the learning rate at each iteration. 
Based on Table 7 and Table 8, it can be seen that the addition of an adaptive learning rate scheme 
to the Momentum Backpropagation can improve system accuracy and reduce the number of epochs 
needed in the training process, so that the time/number of epochs needed for the system to reach its 
convergence point is faster. The reduction in the number of epochs is very significant for each 
dataset, which is a decrease of 390 average epochs from the Backpropagation algorithm and a 
decrease of 80 average epochs from the Backpropagation algorithm with the adaptive learning rate 
scheme. The number of epochs needed for Momentum Backpropagation for each dataset is 228 
epochs for Colon Tumor data, 84 epochs for leukemia data, 617 epochs for Lung Cancer data, and 
628 epochs for Ovarian Cancer data. The number of epochs needed for Backpropagation with an 
adaptive learning rate scheme for each dataset is 189 epochs for Colon Tumor data, 86 epochs for 
leukemia data, 159 epochs for Lung Cancer data, and 189 epochs for Ovarian Cancer data. The 
number of epochs needed for Momentum Backpropagation with an adaptive learning rate scheme 
(proposed scheme) for each dataset is 48 epochs for Colon Tumor data, 39 epochs for leukemia data, 
61 epochs for Lung Cancer data, and 154 epochs for Ovarian Cancer data. Reducing the number of 
epochs required in the training process effect the Neural Network reaching a convergent point 
quickly and the training time required is shorter. 











Momentum Backpropagation 88.85% 98.67% 99.44% 99.61% 96.64% 
Backpropagation with adaptive learning rate 90.51% 98.67% 100.00% 100.00% 97.29% 
Momentum Backpropagation with adaptive 
learning rate 
90.51% 100.00% 100.00% 100.00% 97.63% 
 
Table 8. Number of Epochs Comparison of Optimization Algorithms in Cancer Detection Systems. 
Algorithm 









Momentum Backpropagation 228 84 617 628 390 
Backpropagation with adaptive learning rate 189 86 159 189 156 
Momentum Backpropagation with adaptive 
learning rate 
48 39 61 154 76 
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V. Conclussion 
In this research, an optimization of the Momentum Backpropagation algorithm is done by adding 
an adaptive learning rate scheme as a method of classifying DNA microarray data in a cancer 
detection system. This optimization is done to increase the level of convergence of the Momentum 
Backpropagation algorithm so that the training process can be carried out faster. Genetic Algorithms 
are used as a method of feature selection because the method can automatically select features 
through an evolutionary process. The proposed scheme is proven to improve the accuracy of cancer 
detection and reduce the number of epochs needed in the training process. The number of epochs 
needed for Momentum Backpropagation with an adaptive learning rate scheme for each dataset is 48 
epochs for Colon Tumor data, 39 epochs for leukemia data, 61 epochs for Lung Cancer data, and 
154 epochs for Ovarian Cancer data. The reduction in the number of epochs is very significant for 
each dataset, which is a decrease from 390 epochs (Momentum Backpropagation algorithm) and 156 
epochs (Backpropagation algorithm with the adaptive learning rate scheme) to 76 epochs 
(Momentum Backpropagation algorithm with the adaptive learning rate scheme). Reducing the 
number of epochs required in the training process effect the Neural Network reaching a convergent 
point quickly and the training time required is shorter. The accuracy of cancer detection can be 
achieved using Genetic Algorithm and Momentum Backpropagation algorithm with an adaptive 
learning rate is 90.51% for Colon Tumor data, 100% for Leukemia, 100% for Lung Cancer, and 
100% for Ovarian Cancer data. 
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